ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Felodipine Sustained-Release Tablet Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-36A7630
Home | Market Reports | Health| Pharmacy
Global Felodipine Sustained Release Tablet Market Insights Forecast to 2028
BUY CHAPTERS

Global Felodipine Sustained-Release Tablet Market Research Report 2025

Code: QYRE-Auto-36A7630
Report
July 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Astrazeneca plc
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
LifeOn
Changzhou Siyao Pharmaceutical
Mylan NV
Sandoz Inc

Felodipine Sustained-Release Tablet Market

The global market for Felodipine Sustained-Release Tablet was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Felodipine sustained-release tablets are used to treat hypertension and stable angina pectoris.
North American market for Felodipine Sustained-Release Tablet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Felodipine Sustained-Release Tablet is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Felodipine Sustained-Release Tablet include Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon, Changzhou Siyao Pharmaceutical, Mylan, Sandoz, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Felodipine Sustained-Release Tablet, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Felodipine Sustained-Release Tablet.
The Felodipine Sustained-Release Tablet market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Felodipine Sustained-Release Tablet market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Felodipine Sustained-Release Tablet manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Felodipine Sustained-Release Tablet Market Report

Report Metric Details
Report Name Felodipine Sustained-Release Tablet Market
Segment by Type
  • 2.5mg Per Tablet
  • 5mg Per Tablet
  • Others
Segment by Application
  • Treat High Blood Pressure
  • Relieve Angina
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon, Changzhou Siyao Pharmaceutical, Mylan, Sandoz
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Felodipine Sustained-Release Tablet manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Felodipine Sustained-Release Tablet in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Felodipine Sustained-Release Tablet Market report?

Ans: The main players in the Felodipine Sustained-Release Tablet Market are Astrazeneca, NanJing Easeheal Phaemaecutical, SHANXI KANGBO BIOLOGICAL PRODUCT, Lifeon, Changzhou Siyao Pharmaceutical, Mylan, Sandoz

What are the Application segmentation covered in the Felodipine Sustained-Release Tablet Market report?

Ans: The Applications covered in the Felodipine Sustained-Release Tablet Market report are Treat High Blood Pressure, Relieve Angina, Others

What are the Type segmentation covered in the Felodipine Sustained-Release Tablet Market report?

Ans: The Types covered in the Felodipine Sustained-Release Tablet Market report are 2.5mg Per Tablet, 5mg Per Tablet, Others

1 Felodipine Sustained-Release Tablet Market Overview
1.1 Product Definition
1.2 Felodipine Sustained-Release Tablet by Type
1.2.1 Global Felodipine Sustained-Release Tablet Market Value Comparison by Type (2024 VS 2031)
1.2.2 2.5mg Per Tablet
1.2.3 5mg Per Tablet
1.2.4 Others
1.3 Felodipine Sustained-Release Tablet by Application
1.3.1 Global Felodipine Sustained-Release Tablet Market Value by Application (2024 VS 2031)
1.3.2 Treat High Blood Pressure
1.3.3 Relieve Angina
1.3.4 Others
1.4 Global Felodipine Sustained-Release Tablet Market Size Estimates and Forecasts
1.4.1 Global Felodipine Sustained-Release Tablet Revenue 2020-2031
1.4.2 Global Felodipine Sustained-Release Tablet Sales 2020-2031
1.4.3 Global Felodipine Sustained-Release Tablet Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Felodipine Sustained-Release Tablet Market Competition by Manufacturers
2.1 Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers (2020-2025)
2.2 Global Felodipine Sustained-Release Tablet Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Felodipine Sustained-Release Tablet Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Felodipine Sustained-Release Tablet, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Felodipine Sustained-Release Tablet, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Felodipine Sustained-Release Tablet, Product Type & Application
2.7 Global Key Manufacturers of Felodipine Sustained-Release Tablet, Date of Enter into This Industry
2.8 Global Felodipine Sustained-Release Tablet Market Competitive Situation and Trends
2.8.1 Global Felodipine Sustained-Release Tablet Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Felodipine Sustained-Release Tablet Players Market Share by Revenue
2.8.3 Global Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Felodipine Sustained-Release Tablet Market Scenario by Region
3.1 Global Felodipine Sustained-Release Tablet Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Felodipine Sustained-Release Tablet Sales by Region: 2020-2031
3.2.1 Global Felodipine Sustained-Release Tablet Sales by Region: 2020-2025
3.2.2 Global Felodipine Sustained-Release Tablet Sales by Region: 2026-2031
3.3 Global Felodipine Sustained-Release Tablet Revenue by Region: 2020-2031
3.3.1 Global Felodipine Sustained-Release Tablet Revenue by Region: 2020-2025
3.3.2 Global Felodipine Sustained-Release Tablet Revenue by Region: 2026-2031
3.4 North America Felodipine Sustained-Release Tablet Market Facts & Figures by Country
3.4.1 North America Felodipine Sustained-Release Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Felodipine Sustained-Release Tablet Sales by Country (2020-2031)
3.4.3 North America Felodipine Sustained-Release Tablet Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Felodipine Sustained-Release Tablet Market Facts & Figures by Country
3.5.1 Europe Felodipine Sustained-Release Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Felodipine Sustained-Release Tablet Sales by Country (2020-2031)
3.5.3 Europe Felodipine Sustained-Release Tablet Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Felodipine Sustained-Release Tablet Market Facts & Figures by Region
3.6.1 Asia Pacific Felodipine Sustained-Release Tablet Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2020-2031)
3.6.3 Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Felodipine Sustained-Release Tablet Market Facts & Figures by Country
3.7.1 Latin America Felodipine Sustained-Release Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Felodipine Sustained-Release Tablet Sales by Country (2020-2031)
3.7.3 Latin America Felodipine Sustained-Release Tablet Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Felodipine Sustained-Release Tablet Market Facts & Figures by Country
3.8.1 Middle East and Africa Felodipine Sustained-Release Tablet Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2020-2031)
3.8.3 Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Felodipine Sustained-Release Tablet Sales by Type (2020-2031)
4.1.1 Global Felodipine Sustained-Release Tablet Sales by Type (2020-2025)
4.1.2 Global Felodipine Sustained-Release Tablet Sales by Type (2026-2031)
4.1.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2020-2031)
4.2 Global Felodipine Sustained-Release Tablet Revenue by Type (2020-2031)
4.2.1 Global Felodipine Sustained-Release Tablet Revenue by Type (2020-2025)
4.2.2 Global Felodipine Sustained-Release Tablet Revenue by Type (2026-2031)
4.2.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2020-2031)
4.3 Global Felodipine Sustained-Release Tablet Price by Type (2020-2031)
5 Segment by Application
5.1 Global Felodipine Sustained-Release Tablet Sales by Application (2020-2031)
5.1.1 Global Felodipine Sustained-Release Tablet Sales by Application (2020-2025)
5.1.2 Global Felodipine Sustained-Release Tablet Sales by Application (2026-2031)
5.1.3 Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2020-2031)
5.2 Global Felodipine Sustained-Release Tablet Revenue by Application (2020-2031)
5.2.1 Global Felodipine Sustained-Release Tablet Revenue by Application (2020-2025)
5.2.2 Global Felodipine Sustained-Release Tablet Revenue by Application (2026-2031)
5.2.3 Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2020-2031)
5.3 Global Felodipine Sustained-Release Tablet Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Astrazeneca
6.1.1 Astrazeneca Company Information
6.1.2 Astrazeneca Description and Business Overview
6.1.3 Astrazeneca Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Astrazeneca Felodipine Sustained-Release Tablet Product Portfolio
6.1.5 Astrazeneca Recent Developments/Updates
6.2 NanJing Easeheal Phaemaecutical
6.2.1 NanJing Easeheal Phaemaecutical Company Information
6.2.2 NanJing Easeheal Phaemaecutical Description and Business Overview
6.2.3 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.2.4 NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product Portfolio
6.2.5 NanJing Easeheal Phaemaecutical Recent Developments/Updates
6.3 SHANXI KANGBO BIOLOGICAL PRODUCT
6.3.1 SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
6.3.2 SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview
6.3.3 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.3.4 SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product Portfolio
6.3.5 SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
6.4 Lifeon
6.4.1 Lifeon Company Information
6.4.2 Lifeon Description and Business Overview
6.4.3 Lifeon Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Lifeon Felodipine Sustained-Release Tablet Product Portfolio
6.4.5 Lifeon Recent Developments/Updates
6.5 Changzhou Siyao Pharmaceutical
6.5.1 Changzhou Siyao Pharmaceutical Company Information
6.5.2 Changzhou Siyao Pharmaceutical Description and Business Overview
6.5.3 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product Portfolio
6.5.5 Changzhou Siyao Pharmaceutical Recent Developments/Updates
6.6 Mylan
6.6.1 Mylan Company Information
6.6.2 Mylan Description and Business Overview
6.6.3 Mylan Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Mylan Felodipine Sustained-Release Tablet Product Portfolio
6.6.5 Mylan Recent Developments/Updates
6.7 Sandoz
6.7.1 Sandoz Company Information
6.7.2 Sandoz Description and Business Overview
6.7.3 Sandoz Felodipine Sustained-Release Tablet Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sandoz Felodipine Sustained-Release Tablet Product Portfolio
6.7.5 Sandoz Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Felodipine Sustained-Release Tablet Industry Chain Analysis
7.2 Felodipine Sustained-Release Tablet Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Felodipine Sustained-Release Tablet Production Mode & Process Analysis
7.4 Felodipine Sustained-Release Tablet Sales and Marketing
7.4.1 Felodipine Sustained-Release Tablet Sales Channels
7.4.2 Felodipine Sustained-Release Tablet Distributors
7.5 Felodipine Sustained-Release Tablet Customer Analysis
8 Felodipine Sustained-Release Tablet Market Dynamics
8.1 Felodipine Sustained-Release Tablet Industry Trends
8.2 Felodipine Sustained-Release Tablet Market Drivers
8.3 Felodipine Sustained-Release Tablet Market Challenges
8.4 Felodipine Sustained-Release Tablet Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Astrazeneca plc
NanJing Easeheal Phaemaecutical
SHANXI KANGBO BIOLOGICAL PRODUCT
LifeOn
Changzhou Siyao Pharmaceutical
Mylan NV
Sandoz Inc
List of Tables
 Table 1. Global Felodipine Sustained-Release Tablet Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Felodipine Sustained-Release Tablet Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Felodipine Sustained-Release Tablet Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Felodipine Sustained-Release Tablet Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Felodipine Sustained-Release Tablet Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Felodipine Sustained-Release Tablet Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Felodipine Sustained-Release Tablet Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Felodipine Sustained-Release Tablet, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Felodipine Sustained-Release Tablet, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Felodipine Sustained-Release Tablet, Product Type & Application
 Table 12. Global Key Manufacturers of Felodipine Sustained-Release Tablet, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Felodipine Sustained-Release Tablet by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Felodipine Sustained-Release Tablet as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Felodipine Sustained-Release Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Felodipine Sustained-Release Tablet Sales by Region (2020-2025) & (K Units)
 Table 18. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2020-2025)
 Table 19. Global Felodipine Sustained-Release Tablet Sales by Region (2026-2031) & (K Units)
 Table 20. Global Felodipine Sustained-Release Tablet Sales Market Share by Region (2026-2031)
 Table 21. Global Felodipine Sustained-Release Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2020-2025)
 Table 23. Global Felodipine Sustained-Release Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Felodipine Sustained-Release Tablet Revenue Market Share by Region (2026-2031)
 Table 25. North America Felodipine Sustained-Release Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Felodipine Sustained-Release Tablet Sales by Country (2020-2025) & (K Units)
 Table 27. North America Felodipine Sustained-Release Tablet Sales by Country (2026-2031) & (K Units)
 Table 28. North America Felodipine Sustained-Release Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Felodipine Sustained-Release Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Felodipine Sustained-Release Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Felodipine Sustained-Release Tablet Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Felodipine Sustained-Release Tablet Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Felodipine Sustained-Release Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Felodipine Sustained-Release Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Felodipine Sustained-Release Tablet Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Felodipine Sustained-Release Tablet Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Felodipine Sustained-Release Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Felodipine Sustained-Release Tablet Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Felodipine Sustained-Release Tablet Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Felodipine Sustained-Release Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Felodipine Sustained-Release Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Felodipine Sustained-Release Tablet Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Felodipine Sustained-Release Tablet Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Felodipine Sustained-Release Tablet Sales (K Units) by Type (2020-2025)
 Table 51. Global Felodipine Sustained-Release Tablet Sales (K Units) by Type (2026-2031)
 Table 52. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2020-2025)
 Table 53. Global Felodipine Sustained-Release Tablet Sales Market Share by Type (2026-2031)
 Table 54. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2020-2025)
 Table 57. Global Felodipine Sustained-Release Tablet Revenue Market Share by Type (2026-2031)
 Table 58. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Felodipine Sustained-Release Tablet Sales (K Units) by Application (2020-2025)
 Table 61. Global Felodipine Sustained-Release Tablet Sales (K Units) by Application (2026-2031)
 Table 62. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2020-2025)
 Table 63. Global Felodipine Sustained-Release Tablet Sales Market Share by Application (2026-2031)
 Table 64. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Felodipine Sustained-Release Tablet Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2020-2025)
 Table 67. Global Felodipine Sustained-Release Tablet Revenue Market Share by Application (2026-2031)
 Table 68. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Application (2026-2031)
 Table 70. Astrazeneca Company Information
 Table 71. Astrazeneca Description and Business Overview
 Table 72. Astrazeneca Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Astrazeneca Felodipine Sustained-Release Tablet Product
 Table 74. Astrazeneca Recent Developments/Updates
 Table 75. NanJing Easeheal Phaemaecutical Company Information
 Table 76. NanJing Easeheal Phaemaecutical Description and Business Overview
 Table 77. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. NanJing Easeheal Phaemaecutical Felodipine Sustained-Release Tablet Product
 Table 79. NanJing Easeheal Phaemaecutical Recent Developments/Updates
 Table 80. SHANXI KANGBO BIOLOGICAL PRODUCT Company Information
 Table 81. SHANXI KANGBO BIOLOGICAL PRODUCT Description and Business Overview
 Table 82. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. SHANXI KANGBO BIOLOGICAL PRODUCT Felodipine Sustained-Release Tablet Product
 Table 84. SHANXI KANGBO BIOLOGICAL PRODUCT Recent Developments/Updates
 Table 85. Lifeon Company Information
 Table 86. Lifeon Description and Business Overview
 Table 87. Lifeon Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Lifeon Felodipine Sustained-Release Tablet Product
 Table 89. Lifeon Recent Developments/Updates
 Table 90. Changzhou Siyao Pharmaceutical Company Information
 Table 91. Changzhou Siyao Pharmaceutical Description and Business Overview
 Table 92. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Changzhou Siyao Pharmaceutical Felodipine Sustained-Release Tablet Product
 Table 94. Changzhou Siyao Pharmaceutical Recent Developments/Updates
 Table 95. Mylan Company Information
 Table 96. Mylan Description and Business Overview
 Table 97. Mylan Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Mylan Felodipine Sustained-Release Tablet Product
 Table 99. Mylan Recent Developments/Updates
 Table 100. Sandoz Company Information
 Table 101. Sandoz Description and Business Overview
 Table 102. Sandoz Felodipine Sustained-Release Tablet Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sandoz Felodipine Sustained-Release Tablet Product
 Table 104. Sandoz Recent Developments/Updates
 Table 105. Key Raw Materials Lists
 Table 106. Raw Materials Key Suppliers Lists
 Table 107. Felodipine Sustained-Release Tablet Distributors List
 Table 108. Felodipine Sustained-Release Tablet Customers List
 Table 109. Felodipine Sustained-Release Tablet Market Trends
 Table 110. Felodipine Sustained-Release Tablet Market Drivers
 Table 111. Felodipine Sustained-Release Tablet Market Challenges
 Table 112. Felodipine Sustained-Release Tablet Market Restraints
 Table 113. Research Programs/Design for This Report
 Table 114. Key Data Information from Secondary Sources
 Table 115. Key Data Information from Primary Sources
 Table 116. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Felodipine Sustained-Release Tablet
 Figure 2. Global Felodipine Sustained-Release Tablet Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Felodipine Sustained-Release Tablet Market Share by Type: 2024 & 2031
 Figure 4. 2.5mg Per Tablet Product Picture
 Figure 5. 5mg Per Tablet Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Felodipine Sustained-Release Tablet Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Felodipine Sustained-Release Tablet Market Share by Application: 2024 & 2031
 Figure 9. Treat High Blood Pressure
 Figure 10. Relieve Angina
 Figure 11. Others
 Figure 12. Global Felodipine Sustained-Release Tablet Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Felodipine Sustained-Release Tablet Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Felodipine Sustained-Release Tablet Sales (2020-2031) & (K Units)
 Figure 15. Global Felodipine Sustained-Release Tablet Average Price (US$/Unit) & (2020-2031)
 Figure 16. Felodipine Sustained-Release Tablet Report Years Considered
 Figure 17. Felodipine Sustained-Release Tablet Sales Share by Manufacturers in 2024
 Figure 18. Global Felodipine Sustained-Release Tablet Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Felodipine Sustained-Release Tablet Players: Market Share by Revenue in Felodipine Sustained-Release Tablet in 2024
 Figure 20. Felodipine Sustained-Release Tablet Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Felodipine Sustained-Release Tablet Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Felodipine Sustained-Release Tablet Sales Market Share by Country (2020-2031)
 Figure 23. North America Felodipine Sustained-Release Tablet Revenue Market Share by Country (2020-2031)
 Figure 24. United States Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Felodipine Sustained-Release Tablet Sales Market Share by Country (2020-2031)
 Figure 27. Europe Felodipine Sustained-Release Tablet Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Felodipine Sustained-Release Tablet Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Felodipine Sustained-Release Tablet Revenue Market Share by Region (2020-2031)
 Figure 35. China Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Felodipine Sustained-Release Tablet Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Felodipine Sustained-Release Tablet Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Felodipine Sustained-Release Tablet Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Felodipine Sustained-Release Tablet Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Felodipine Sustained-Release Tablet Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Felodipine Sustained-Release Tablet by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Felodipine Sustained-Release Tablet by Type (2020-2031)
 Figure 56. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Felodipine Sustained-Release Tablet by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Felodipine Sustained-Release Tablet by Application (2020-2031)
 Figure 59. Global Felodipine Sustained-Release Tablet Price (US$/Unit) by Application (2020-2031)
 Figure 60. Felodipine Sustained-Release Tablet Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS

Global Felodipine Tablets Market Research Report 2025
Global Amlodipine Market Research Report 2024
Global Nicardipine Hydrochloride Tablets Market Research Report 2025
Global Felodipine Market Research Report 2025
Global Alfuzosin Hydrochloride Sustained Release Tablets Market Research Report 2024
Global Diltiazem Hydrochloride Extended Release Tablets Market Research Report 2025
Global Amlodipine Besylate Tablets Market Research Report 2024
Global Amlodipine Besilate Market Research Report 2024
Global Amlodipine Besylate Capsule Market Research Report 2025
Global Verapamil Hydrochloride Tablets Market Research Report 2025
Global Nilvadipine Market Research Report 2024
Global Diltiazem Calcium Channel Blocker Market Research Report 2025
Global Perindopril tert Butylamine Tablets Market Research Report 2024
Diltiazem Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Lercanidipine Hydrochloride Tablets Market Research Report 2024
Global Metformin Hydrochloride Sustained release Tablets Market Research Report 2024
Tamsulosin Hydrochloride Sustained Release Capsules Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Irbesartan Amlodipine Tablets Market Research Report 2024
Global Nifedipine Tablets Market Research Report 2024
Global Diltiazem Hydrochloride Tablets Market Research Report 2025

RELATED REPORTS

Global GLP-1 Targeted Peptide Weight Loss Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19A18322
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Stimulant-Free Fat Burners Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3E3525
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Test Boosters Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-35T3049
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Salsalate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-33Y1801
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions